{"id":"W2335022045","doi":"10.1097/spc.0000000000000022","title":"New agents in locally advanced breast cancer","year":2013,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Trastuzumab; Neoadjuvant therapy; Breast cancer; Taxane; Oncology; Targeted therapy; Anthracycline; Chemotherapy; Clinical trial; Internal medicine; Bevacizumab; PI3K/AKT/mTOR pathway; Cancer; Bioinformatics; Signal transduction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003958896,0.0009698735,0.001443819,0.001892633,0.0002421767,0.0007403052,0.0009195257,0.0009683195,0.004277688],"category_scores_gemma":[0.0006184769,0.0002771312,0.0004947601,0.001642977,0.0004038231,0.001075744,0.0005601021,0.002204916,0.003685462],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004880318,"about_ca_system_score_gemma":0.0006150933,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007218837,"about_ca_topic_score_gemma":0.001391033,"domain_scores_codex":[0.9998485,0.00002415241,0.00002426649,0.00002668657,0.00006131777,0.00001512695],"domain_scores_gemma":[0.9997991,0.0000831498,0.00004169602,0.000006919327,0.00004950458,0.00001966889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007662534,0.00006809014,0.00007834931,0.01365612,0.00006868461,0.000235959,0.00003289307,0.0002981948,0.001378763,0.001681467,0.03130006,0.9511248],"study_design_scores_gemma":[0.00003037476,0.00007398937,0.0004540519,0.002440972,0.00007609207,0.001697769,0.00002674652,0.00006663067,0.0004646151,0.0006767653,0.9939795,0.00001241022],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009532021,0.9982598,0.000104981,0.0001620263,0.0002697762,0.000008492484,0.00001925454,0.000009649712,0.001070606],"genre_scores_gemma":[0.0006265737,0.9978722,0.0002093501,0.0002560369,0.0001975493,0.00001374144,0.00004027924,0.000002659267,0.0007814264],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004277688,"threshold_uncertainty_score":0.01431024,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.104473817635909,"score_gpt":0.4338331858408241,"score_spread":0.3293593682049151,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}